Imaging in systemic vasculitis

Current Opinion in Rheumatology

Volumn 27, Issue 1, 2015, Pages 53-62

  Prieto González, Sergio ^b   Arguis, Pedro ^a   Cid, Maria C ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Color duplex ultrasonography; Computed tomography angiography; Magnetic resonance angiography; Positron emission tomography; Vasculitis

Indexed keywords

BEHCET DISEASE; BLOOD VESSEL BIOPSY; CARDIAC IMAGING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; HUMAN; LARGE VESSEL VASCULITIS; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; RHEUMATIC POLYMYALGIA; SMALL VESSEL VASCULITIS; SYSTEMIC VASCULITIS; TEMPORAL ARTERY; DIAGNOSTIC IMAGING; PROCEDURES; REPRODUCIBILITY;

DIAGNOSTIC IMAGING; HUMANS; REPRODUCIBILITY OF RESULTS; SYSTEMIC VASCULITIS;

EID: 84918510729     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000130     Document Type: Review

References (86)

1. Schmidt WA. Ultrasound in vasculitis. Clin Exp Rheumatol 2014; 32:S71- S77.
2. Agard C, Barrier JH, Dupas B, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: A case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008; 59:670-676.
3. Prieto-González S, Arguis P, Garcia-Martinez A, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012; 71:1170-1176.
4. Koenigkam-Santos M, Sharma P, Kalb B, et al. Magnetic resonance angiography in extracranial giant cell arteritis. J Clin Rheumatol 2011; 17:306- 310.
5. Blockmans D. PET in vasculitis. Ann N Y Acad Sci 2011; 1228:64-70.
6. Cid MC, Prieto-González S, Arguis P, et al. The spectrum of vascular involvement in giant-cell arteritis: clinical consequences of detrimental vascular remodelling at different sites. APMIS 2009; 117:10-20.
7. Cid MC, Font C, Coll-Vinent B, Grau JM. Large vessel vasculitides. Curr Opin Rheumatol 1998; 10:18-28.
8. Blockmans D, Bley T, Schmidt W. Imaging for large-vessel vasculitis. Curr Opin Rheumatol 2009; 21:19-28.
9. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65:1-11.
10. Schmidt WA, Natusch A, Moller DE, et al. Involvement of peripheral arteries in giant cell arteritis: A color Doppler sonography study. Clin Exp Rheumatol 2002; 20:309-318.
11. Blockmans D, de Ceuninck L, Vanderschueren S, et al. Repetitive 18Ffluorodeoxyglucose positron emission tomography in giant cell arteritis: A prospective study of 35 patients. Arthritis Rheum 2006; 55:131- 137.
12. Agard C, Hamidou MA, Said L, et al. Screening of abdominal aortic involvement using Doppler sonography in active giant cell (temporal) arteritis at the time of diagnosis: A prospective study of 30 patients. Rev Med Interne 2007; 28:363-370.
13. Schmidt WA, Seifert A, Gromnica-Ihle E, et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 2008; 47:96-101.
14. Aschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 2010; 69:1356-1359.
15. Ghinoi A, Pipitone N, Nicolini A, et al. Large-vessel involvement in recentonset giant cell arteritis: A case-control colour-Doppler sonography study. Rheumatology (Oxford) 2012; 51:730-734.
16. Diamantopoulos AP, Haugeberg G, Hetland H, et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: A consecutive case series. Arthritis Care Res (Hoboken) 2014; 66:113-119.
17. Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behcet's disease: An update. Curr Opin Rheumatol 2011; 23:24-31.
18. Chirinos JA, Tamariz LJ, Lopes G, et al. Large vessel involvement in ANCAassociated vasculitides: report of a case and review of the literature. Clin Rheumatol 2004; 23:152-159.
19. Kasashima S, Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol 2011; 23:18-23.
20. Schmidt J, Sunesen K, Kornum JB, et al. Predictors for pathologically confirmed aortitis after resection of the ascending aorta: A 12-year Danish nationwide population-based cross-sectional study. Arthritis Res Ther 2011; 13:R87.
21. Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005; 17:9-15.
22. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: Test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005; 142:359-369.
23. Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: A second meta-analysis. BMC Musculoskelet Disord 2010; 11:44.
24. Ball EL, Walsh SR, Tang TY, et al. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010; 97:1765-1771.
25. García-García J, Ayo-Martín O, Argandona-Palacios L, Segura T. Vertebral artery halo sign in patients with stroke: A key clue for the prompt diagnosis of giant cell arteritis. Stroke 2011; 42:3287-3290.
26. Karahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: A prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 2006; 8:R116.
27. Germano G, Muratore F, Cimino L, et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology (Oxford) 2014.
28. Muratore F, Boiardi L, Restuccia G, et al. Comparison between colour duplex sonography findings and different histological patterns of temporal artery. Rheumatology (Oxford) 2013; 52:2268-2274.
29. Feinstein SB, Coll B, Staub D, et al. Contrast enhanced ultrasound imaging. J Nucl Cardiol 2010; 17:106-115.
30. Ten Kate GL, van den Oord SC, Sijbrands EJ, et al. Current status and future developments of contrast-enhanced ultrasound of carotid atherosclerosis. J Vasc Surg 2013; 57:539-546.
31. Giordana P, Baque-Juston MC, Jeandel PY, et al. Contrast-enhanced ultrasound of carotid artery wall in Takayasu disease: First evidence of application in diagnosis and monitoring of response to treatment. Circulation 2011; 124:245-247.
32. Magnoni M, Dagna L, Coli S, et al. Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound. Circ Cardiovasc Imaging 2011; 4:e1-e2.
33. Schinkel AF, van den Oord SC, van der Steen AF, et al. Utility of contrastenhanced ultrasound for the assessment of the carotid artery wall in patients with Takayasu or giant cell arteritis. Eur Heart J Cardiovasc Imaging 2014; 15:541-546.
34. Mason JC. Takayasu arteritis: Advances in diagnosis and management. Nat Rev Rheumatol 2010; 6:406-415.
35. Zhu FP, Luo S, Wang ZJ, et al. Takayasu arteritis: Imaging spectrum at multidetector CT angiography. Br J Radiol 2012; 85:e1282-e1292.
36. Fleischmann D, Mitchell RS, Miller DC. Acute aortic syndromes: new insights from electrocardiographically gated computed tomography. Semin Thorac Cardiovasc Surg 2008; 20:340-347.
37. Khandelwal N, Kalra N, Garg MK, et al. Multidetector CT angiography in Takayasu arteritis. Eur J Radiol 2011; 77:369-374.
38. Hartlage GR, Palios J, Barron BJ, et al. Multimodality imaging of aortitis. JACC Cardiovasc Imaging 2014; 7:605-619.
39. Kim SY, Park JH, Chung JW, et al. Follow-up CT evaluation of the mural changes in active Takayasu arteritis. Korean J Radiol 2007; 8:286-294.
40. Chung JW, Kim HC, Choi YH, et al. Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 2007; 45:906-914.
41. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2004; 16:31-37.
42. Alkadhi H, Schindera ST. State of the art low-dose CT angiography of the body. Eur J Radiol 2011; 80:36-40.
43. Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: A population-based study over 50 years. Arthritis Rheum 2003; 48:3522-3531.
44. Kermani TA, Warrington KJ, Crowson CS, et al. Large-vessel involvement in giant cell arteritis: A population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2013; 72:1989-1994.
45. Robson JC, Kiran A, Maskell J, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rheum Dis 2013. [Epub ahead of print].
46. García-Martínez A, Hernández-Rodríguez J, Arguis P, et al. Development of aortic aneurysm/dilatation during the follow up of patients with giant cell arteritis: A cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008; 59:422-430.
47. García-Martínez A, Arguis P, Prieto-González S, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis 2014; 73:1826- 1832.
48. Kang EJ, Kim SM, Choe YH, et al. Takayasu arteritis: Assessment of coronary arterial abnormalities with 128-section dual-source CT angiography of the coronary arteries and aorta. Radiology 2014; 270:74-81.
49. Tso E, Flamm SD, White RD, et al. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002; 46:1634-1642.
50. Isobe M. The Asia Pacific meeting on vasculitis and ANCA 2012 workshop on Takayasu arteritis: Advances in diagnosis and medical treatment. Clin Exp Nephrol 2013; 17:686-689.
51. Papa M, De Cobelli F, Baldissera E, et al. Takayasu arteritis: Intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 2012; 198:W279-W284.
52. Eshet Y, Pauzner R, GoiteinO, et al. The limited role ofMRI in long-term followup of patients with Takayasu's arteritis. Autoimmun Rev 2011; 11:132-136.
53. Bley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 2008; 58:2574-2578.
54. Klink T, Geiger J, Both M, et al. Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology 2014. [Epub ahead of print].
55. Veldhoen S, Klink T, Geiger J, et al. MRI displays involvement of the temporalis muscle and the deep temporal artery in patients with giant cell arteritis. Eur Radiol 2014; 24:2971-2979.
56. Fuchs M, Briel M, Daikeler T, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012; 39:344-353.
57. Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 2008; 47:1179-1184.
58. Besson FL, Parienti JJ, Bienvenu B, et al. Diagnostic performance of (1)Ffluorodeoxyglucose positron emission tomography in giant cell arteritis: A systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011; 38:1764-1772.
59. Martínez-Rodríguez I, Martínez-Amador N, Banzo I, et al. Assessment of aortitis by semiquantitative analysis of 180-min F-FDG PET/CT acquisition images. Eur J Nucl Med Mol Imaging 2014. [Epub ahead of print].
60. Small GR, Ruddy TD. PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality? J Nucl Cardiol 2011; 18:717-728.
61. Orellana MR, Bentourkia M, Sarrhini O, et al. Assessment of inflammation in large arteries with 18F-FDG-PET in elderly. Comput Med Imaging Graph 2013; 37:459-465.
62. Prieto-González S, Depetris M, García-Martínez A, et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: A prospective, case-control study. Ann Rheum Dis 2014; 73:1388-1392.
63. Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole-body fluorine- 18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: A systematic review. Clin Rheumatol 2011; 30:1265-1275.
64. Santhosh S, Mittal BR, Gayana S, et al. F-18 FDG PET/CT in the evaluation of Takayasu arteritis: An experience from the tropics. J Nucl Cardiol 2014; 21:993-1000.
65. Cheng Y, Lv N, Wang Z, et al. 18-FDG-PET in assessing disease activity in Takayasu arteritis: A meta-analysis. Clin Exp Rheumatol 2013; 31:S22-S27.
66. Cagnin A, Kassiou M, Meikle SR, Banati RB. Positron emission tomography imaging of neuroinflammation. Neurotherapeutics 2007; 4:443-452.
67. Pugliese F, Gaemperli O, Kinderlerer AR, et al. Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography/computed tomography angiography. J Am Coll Cardiol 2010; 56:653-661.
68. Hauenstein C, Reinhard M, Geiger J, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultras onography findings in giant cell arteritis. Rheumatology (Oxford) 2012; 51:1999-2003.
69. Santoro L, D'Onofrio F, Bernardi S, et al. Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment. Rheumatology (Oxford) 2013; 52:622.
70. Prieto-Gonzalez S, Garcia-Martinez A, Arguis P, Cid MC. Early improvement of radiological signs of large-vessel inflammation in giant cell arteritis upon glucocorticoid treatment. Rheumatology (Oxford) 2013; 52:1335-1336.
71. Tezuka D, Haraguchi G, Ishihara T, et al. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging 2012; 5:422-429.
72. Lee KH, Cho A, Choi YJ, et al. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis. Arthritis Rheum 2012; 64:866-875.
73. Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012; 8:509-521.
74. Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012; 71:484-492.
75. Salvarani C, Barozzi L, Cantini F, et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 2008; 67:758-761.
76. Salvarani C, Barozzi L, Boiardi L, et al. Lumbar interspinous bursitis in active polymyalgia rheumatica. Clin Exp Rheumatol 2013; 31:526-531.
77. Adams H, Raijmakers P, Smulders Y. Polymyalgia rheumatica and interspinous FDG uptake on PET/CT. Clin Nucl Med 2012; 37:502-505.
78. Blockmans D, De Ceuninck L, Vanderschueren S, et al. Repetitive 18- fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: A prospective study in 35 patients. Rheumatology (Oxford) 2007; 46:672-677.
79. Bourgarit A, Le Toumelin P, Pagnoux C, et al. Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: A retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 2005; 84:323-330.
80. Guillevin L, Cohen P, Gayraud M, et al.Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999; 78:26-37.
81. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation 2004; 109:1250-1258.
82. Marmursztejn J, Guillevin L, Trebossen R, et al. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: A prospective study on 20 patients. Rheumatology (Oxford) 2013; 52:642-650.
83. Soussan M, Abisror N, Abad S, et al. FDG-PET/CT in patients with ANC Aassociated vasculitis: case-series and literature review. Autoimmun Rev 2014; 13:125-131.
84. Ito K, Minamimoto R, Yamashita H, et al. Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Ann Nucl Med 2013; 27:209-216.
85. Uzun O, Akpolat T, Erkan L. Pulmonary vasculitis in behcet disease: A cumulative analysis. Chest 2005; 127:2243-2253.
86. Cho SB, Yun M, Lee JH, et al. Detection of cardiovascular system involvement in Behcet's disease using fluorodeoxyglucose positron emission tomography. Semin Arthritis Rheum 2011; 40:461-466.